INDP (Indaptus Therapeutics) FFO


INDP Indaptus Therapeutics Inc INDP
26 GF Score
Price $3.37
! 1 Warning Sign
View Full Analysis

What is Indaptus Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

INDP
26GF Score
Indaptus Therapeutics Inc INDP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indaptus Therapeutics Business Description

Address 3 Columbus Circle 15th Floor, New York, NY, USA, 10019
Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.
26GF Score

Get the complete analysis for INDP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.37
Price